[89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial.
The Lancet. Oncology · 2024 · 122 citations · Allan Pantuck
Antibody-Drug Conjugates: A Review of Approved Drugs and Their Clinical Level of Evidence.
Cancers · 2023 · 153 citations · Sidharth Bhasin
Injuries With Electric vs Conventional Scooters and Bicycles.
JAMA network open · 2024 · 30 citations · Hiren Patel
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026 · 14 citations · Parth Modi
Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non-Muscle-Invasive Bladder Cancer.
JAMA network open · 2023 · 99 citations · Vignesh Packiam
A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder Cancer.
European urology · 2025 · 40 citations · Saum Ghodoussipour
Effects of Advanced Practice Providers on Single-specialty Surgical Practice.
Annals of surgery · 2023 · 38 citations · Parth Modi
Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center Cohort.
The Journal of urology · 2025 · 31 citations · Vignesh Packiam